To Ablate Or Not To Ablate: Current Management of Atrial Fibrillation

OSUWexnerbloglogo2014 CME Webcast Discusses To Ablate Or Not To Ablate Current Management of Atrial Fibrillation. In 1998, Dr. Michel Hice-uh-gaire, a cardiologist in Bordeaux, France, determined that the electrical triggers for atrial fibrillation were most commonly located in the pulmonary veins and that he could cure atrial fibrillation by ablating these triggers with a catheter. In the 2 decades since, ablation has a key element in the cardiologist’s toolbox to treat atrial fibrillation. But which patients are best served by medical treatment and which ones are best treated with catheter ablation? On this CME webcast, we’re going to explore this question. Joining our moderator is cardiac electrophysiologist and Professor of Internal Medicine at the Ohio State University, Dr. John Hummel.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Understand the risks of atrial fibrillation; and Understand when to initiate a strategy to maintain sinus rhythm.

You’ll also learn about the following:

  • Clinical implications of atrial fibrillation
  • Patient selection for atrial ablation
  • The ablation procedure
  • Return to work and exercise
  • Medication management after atrial ablation
  • Maze procedure
  • Management of recurrent atrial fibrillation after an ablation procedure
  • Apple Watch EKG app

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Watch CME Webcast on Moderate and Deep Sedation

OSUWexnerbloglogo2014 Watch CME Webcast on Moderate and Deep Sedation. On this CME Webcast, we’re going to cover what you need to know in order to assess the patient before the procedure, how to choose the best sedative medication for the procedure, how to monitor the patient during the procedure, and how to recover the patient after the procedure. We’re also going to talk about some of the common things that can go wrong, how to anticipate them, and how to manage complications when they occur. With us today to discuss airway assessment and basic airway rescue is Assistant Professor of Anesthesiology, Dr. John Rogoski. And to discuss the medications we use in sedation, PharmD and Associate Professor of Pharmacy, Mary Beth Shirk.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY risk factors associated with difficult mask ventilation and difficult intubation; and DESCRIBE maneuvers and devices utilized to overcome airway obstruction

You’ll also learn about the following:

  • Common risks of sedation
  • Individualizing the sedation plan
  • Airway Management
  • STOP-BANG
  • Agents for Procedural Sedation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Watch On-line CME Webcast About Uncontrolled Diabetes

OSUWexnerbloglogo2014 Watch On-line CME Webcast About Uncontrolled Diabetes. Hemoglobin A1C measurement is a test that you likely use in your practice every day and when the hemoglobin A1C is very high, it is a sign that the patient’s diabetes has been poorly controlled. On this CME Webcast, we’re going to discuss uncontrolled diabetes. First, to tell us about the medical management of uncontrolled diabetes, endocrinologist and Associate Professor of Internal Medicine, Dr. Kathleen Dungan. And then tell us about the role of diabetic education, nurse and OSU diabetic educator, Janet Zappe.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: COMPARE and contrast the mechanisms of action, efficacy, side effects, and contra-indications of glucose lowering agents for type 2 diabaetes; and UNDERSTAND how to intensify glucose lowering agents to meet individualized patient targets.

You’ll also learn about the following:

  • The ideal hemoglobin A1C level
  • The role of the diabetes educator
  • When to refer
  • Home glucose monitoring
  • Incorporating diabetes education into the primary care practice

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.